Success Metrics

Clinical Success Rate
92.3%

Based on 36 completed trials

Completion Rate
92%(36/39)
Active Trials
7(12%)
Results Posted
14%(5 trials)
Terminated
3(5%)

Phase Distribution

Ph phase_1
5
9%
Ph phase_2
7
12%
Ph phase_3
7
12%
Ph not_applicable
25
44%
Ph phase_4
9
16%

Phase Distribution

5

Early Stage

7

Mid Stage

16

Late Stage

Phase Distribution53 total trials
Phase 1Safety & dosage
5(9.4%)
Phase 2Efficacy & side effects
7(13.2%)
Phase 3Large-scale testing
7(13.2%)
Phase 4Post-market surveillance
9(17.0%)
N/ANon-phased studies
25(47.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

36 of 40 finished

Non-Completion Rate

10.0%

4 ended early

Currently Active

7

trials recruiting

Total Trials

57

all time

Status Distribution
Active(9)
Completed(36)
Terminated(4)
Other(8)

Detailed Status

Completed36
unknown8
Recruiting5
Terminated3
Active, not recruiting2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
57
Active
7
Success Rate
92.3%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (9.4%)
Phase 27 (13.2%)
Phase 37 (13.2%)
Phase 49 (17.0%)
N/A25 (47.2%)

Trials by Status

terminated35%
withdrawn12%
completed3663%
active_not_recruiting24%
unknown814%
not_yet_recruiting24%
recruiting59%

Recent Activity

Clinical Trials (57)

Showing 20 of 57 trialsScroll for more
NCT07105618Not Applicable

Total Intravenous Anesthesia in Patients Undergoing Craniotomy

Recruiting
NCT07521358Not Applicable

Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression

Completed
NCT07502482

The Effect of Magnesium on Post-spinal Headaches

Not Yet Recruiting
NCT05488847Phase 4

Opioid-Free Pain Protocol After Shoulder Arthroplasty

Active Not Recruiting
NCT06904287Phase 3

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

Recruiting
NCT07309640Not Applicable

The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With Transverse Maxillary Deficiency (TMD)

Not Yet Recruiting
NCT06721247Phase 2

Oral Intake of Mg in Controlled Asthmatic Patients

Active Not Recruiting
NCT07082894Not Applicable

Effect of Preoperative Oral Magnesium on Emergence Agitation

Recruiting
NCT07079514Phase 1

Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients

Completed
NCT05806996Phase 2

A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures

Recruiting
NCT02521753Not Applicable

Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients

Terminated
NCT05862454

Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise

Recruiting
NCT05065528Not Applicable

Mag Con: Efficacy of Oral Mag. in Acute Concussion in Adolescents

Withdrawn
NCT06091007Not Applicable

Magnesium Citrate Supplementation on Hand Grip Strength

Completed
NCT06332248Not Applicable

Possible Effects of the Dietary Supplement Magnesium Compared to Placebo

Completed
NCT06077539Phase 1

Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics

Unknown
NCT06059833

Serum Magnesium Level in Type 2 Diabetes Mellitus

Unknown
NCT05931965Not Applicable

Combination Therapy of Different Antidepressants With Dietary Supplements

Completed
NCT05149820Phase 4

Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments

Unknown
NCT03033823Phase 3

MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
57